Trademark: 79270732
Word
NEURALCIM
Status Date
Monday, June 15, 2020
Filing Date
Thursday, August 16, 2018
Abandoned Date
Wednesday, June 3, 2020
5 Pharmaceutical preparations for treatment of diseases of the central nervous system, such as nasal pharmaceutical formulation of non-hematopoietic erythropoietin for treatment of diseases of the central nervous system
The color(s) blue is/are claimed as a feature of the mark.
NEURAL CIM
Nov 19, 2021
New Representative At Ib Received
Jul 4, 2021
Final Decision Transaction Processed By Ib
Jun 15, 2021
Final Disposition Notice Sent To Ib
Jun 15, 2021
Final Disposition Notice Created, To Be Sent To Ib
Apr 18, 2021
Notification Of Possible Opposition - Processed By Ib
Mar 31, 2021
Notification Of Possible Opposition Sent To Ib
Mar 31, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 15, 2020
Abandonment Notice Mailed - Failure To Respond
Jun 15, 2020
Abandonment - Failure To Respond Or Late Response
Dec 21, 2019
Refusal Processed By Ib
Dec 3, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Dec 2, 2019
Refusal Processed By Mpu
Nov 12, 2019
Application Filing Receipt Mailed
Nov 8, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Nov 7, 2019
Non-Final Action Written
Nov 7, 2019
Assigned To Examiner
Nov 7, 2019
New Application Office Supplied Data Entered In Tram
Oct 31, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
